Nobel Laureate Joins the Scientific Advisory Board of Insilico Medicine, Inc. in Combatting Aging and Age-Related Diseases

2013 Nobel Laureate Michael Levitt is Insilico Medicine's latest Scientific Advisory Board addition in the pursuit of working interventions towards aging and aging-related disease. United with the board's current expertise, Dr. Levitt's background in computational biology will facilitate the company's effort to achieve novel drug discovery and personalized medicine.